What is Liquid-Based Thin-Layer Cytology?

The liquid-based thin-layer cytology test is an examination of cervical cytology and a means of screening for cervical cancer. It is clinically referred to as TCT. Under normal conditions, TCT shows no abnormalities. This test uses a liquid-based thin-layer cell detection system to detect cervical cells and perform cytological classification diagnosis. It is currently the most advanced cervical cancer cytology examination technique internationally. Compared with traditional cervical scraping Pap smear examination, it significantly improves the satisfaction of specimens and the detection rate of abnormal cervical cells. The TCT cervical cancer prevention cytology examination has a 100% detection rate for cervical cancer cells, and can also detect some precancerous lesions and microbial infections such as mold, trichomonas, viruses, and chlamydia. Therefore, TCT technology is the most advanced technique applied to screening for cervical cancer in women.

Compared with traditional cervical scraping Pap smear examination, the liquid-based thin-layer cytology test significantly improves the satisfaction of specimens and the detection rate of abnormal cervical cells. The TCT cervical cancer prevention cytology examination has a 100% detection rate for cervical cancer cells, and can also detect some precancerous lesions and microbial infections such as mold, trichomonas, viruses, and chlamydia. Therefore, TCT technology is the most advanced technique applied to screening for cervical cancer in women. Cervical TCT examination significantly improves the detection quality of cervical cell samples. Due to factors such as blood, mucus, and inflammation, conventional Pap smears often make the samples blurry and have detection errors. In clinical experiments, cervical TCT examination can significantly improve the detection rate of cancerous cells by testing the number of blurry cervical cell samples, and correspondingly reduce the number of repeat Pap tests required, thereby reducing unnecessary concerns caused by patients being required to redo the test. The reduction in errors in conventional Pap smears is bound to improve the detection of early carcinogenesis to a new stage and enable earlier and more effective treatment for those patients with early carcinogenesis.